Prevalence and number of circulating tumour cells and microemboli at diagnosis of advanced NSCLC
Prevalence and number of circulating tumour cells and microemboli at diagnosis of advanced NSCLC
About this item
Full title
Author / Creator
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Purpose
Timing and magnitude of blood release of circulating tumour cells (CTC) and circulating tumour microemboli (CTM) from primary solid cancers are uncertain. We investigated prevalence and number of CTC and CTM at diagnosis of advanced non-small cell lung cancer (NSCLC).
Methods
Twenty-eight consecutive patients with suspected stage I...
Alternative Titles
Full title
Prevalence and number of circulating tumour cells and microemboli at diagnosis of advanced NSCLC
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1760870929
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1760870929
Other Identifiers
ISSN
0171-5216
E-ISSN
1432-1335
DOI
10.1007/s00432-015-2021-3
